Literature DB >> 18473808

BK channel modulators: a comprehensive overview.

Antonio Nardi1, Søren-Peter Olesen.   

Abstract

The large Ca(2+)-activated K(+) channel (BK channel) reflects per excellence the dilemma of the molecular target driven drug discovery process. Significant experimental evidence suggests that the BK channels play a pivotal and specific role in many pathophysiological conditions supporting the notion that the channel represents an innovative and promising drug target. However, after more than ten years of intense research effort both in academia and industry, scientists have yet to witness the approval of a single BK channel modulator for clinical use. On the contrary, three BK openers that were progressed to clinical development have recently been discontinued (NS8, BMS204352 and TA1702) and, at the present time, only one drug candidate targeting BK channels (andolast) remains in the early phases of clinical development. Since biological studies keep strengthening the concept of BK channels as a potentially attractive target, the design and synthesis of potent and selective BK modulators continue based on novel chemical ideas. A comprehensive overview of BK channel modulators is therefore timely and important to the current medicinal chemist for review, summary, and classification of the multitude of chemical entities claimed to be BK-modulating agents. Such chemical entities are, herein, classified by both origin and chemical structure in 1) Endogenous BK channel modulators and structural analogues 2) Naturally-occurring BK channel inhibitors and blockers 3) Synthetic BK channel inhibitors and blockers 4) Marketed and/or investigational drugs with BK-modulating side properties and structural analogues 5) Naturally-occurring BK channel openers and structural analogues 6) Synthetic BK channel openers. This review is intended to provide readers with current opinion on the BK channel as a drug target, the chemical structures of BK channel modulators, the structural and chemical features involved in the BK channel modulating activity and, where and when possible, with highlights of structure-activity relationships.

Mesh:

Substances:

Year:  2008        PMID: 18473808     DOI: 10.2174/092986708784221412

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  67 in total

1.  Molecular mechanism of pharmacological activation of BK channels.

Authors:  Guido Gessner; Yong-Mei Cui; Yuko Otani; Tomohiko Ohwada; Malle Soom; Toshinori Hoshi; Stefan H Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

Review 2.  Vasodilatory mechanisms of beta receptor blockade.

Authors:  Géraldine Rath; Jean-Luc Balligand; Chantal Dessy; Dessy Chantal
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

3.  BK channels mediate a novel ionic mechanism that regulates glucose-dependent electrical activity and insulin secretion in mouse pancreatic β-cells.

Authors:  Khaled M Houamed; Ian R Sweet; Leslie S Satin
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

Review 4.  2014 Conway review lecture, Royal Academy of Medicine in Ireland: “S6, drugs and RCK and Bowl”.

Authors:  M A Hollywood
Journal:  Ir J Med Sci       Date:  2016-02       Impact factor: 1.568

Review 5.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 6.  Targeting BKCa Channels in Migraine: Rationale and Perspectives.

Authors:  Mohammad Al-Mahdi Al-Karagholi; Christian Gram; Cherie Amalie Waldorff Nielsen; Messoud Ashina
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

7.  Celastrol Dilates and Counteracts Ethanol-Induced Constriction of Cerebral Arteries.

Authors:  Kelsey North; Alexandria Slayden; Steven Mysiewicz; Anna Bukiya; Alex Dopico
Journal:  J Pharmacol Exp Ther       Date:  2020-08-29       Impact factor: 4.030

8.  14-3-3γ, a novel regulator of the large-conductance Ca2+-activated K+ channel.

Authors:  Shan Chen; Xiuyan Feng; Xinxin Chen; Zhizhi Zhuang; Jia Xiao; Haian Fu; Janet D Klein; Xiaonan H Wang; Robert S Hoover; Douglas C Eaton; Hui Cai
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

Review 9.  Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.

Authors:  Ralf Köhler; Brajesh P Kaistha; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2010-02       Impact factor: 6.902

10.  Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Andrew N Cornforth; Daniela A Bota; Anthony Mai; Dong In Kim; Shiun-Kwei Chiou; Michelle J Hickey; Carol A Kruse; Martin R Jadus
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.